R. Baxter

Signaling Pathways of the Insulin-like Growth Factor Binding Proteins
202384 citationsauthor #1
Displacement of Native FXYD Protein From Na+/K+-ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity
20227 citationsauthor #7
Noncoding RNA actions through IGFs and IGF binding proteins in cancer
202221 citationsauthor #2
Acknowledgement to reviewers
20220 citationsauthor #31
Amphiregulin increases migration and proliferation of epithelial ovarian cancer cells by inducing its own expression via PI3-kinase signaling.
202112 citationsauthor #3
Na+/K+-ATPase-associated FXYD3 Protein As An Intracellular Therapeutic Target in Cancer
20200 citationsauthor #8
The role of the free β-subunit of human chorionic gonadotropin in human malignancy
20200 citationsauthor #2
Contrasting effects of IGF binding protein‐3 expression in mammary tumor cells and the tumor microenvironment
20195 citationsauthor #6
Novel Prognostic Markers in Triple-Negative Breast Cancer Discovered by MALDI-Mass Spectrometry Imaging
201932 citationsauthor #3
IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer
201971 citationsauthor #5
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)
201941 citationsauthor #8
Enhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulation.
201819 citationsauthor #7
Abstract 789: Nuclear IGFBP-3 is a potential biomarker for response to EGFR-sphingosine kinase targeted therapy in basal-like triple-negative breast cancer (TNBC)
20180 citationsauthor #3
Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotherapy
201819 citationsauthor #3
Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade
201730 citationsauthor #6
Limitations of galactose therapy in phosphoglucomutase 1 deficiency
201735 citationsauthor #11
Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer
201712 citationsauthor #2
Patent Number : 45 Date of Patent : 5 , 324 , 820 Jun . 28 , 1994
20170 citationsauthor #1
Additional file 7: of Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer
20170 citationsauthor #2
Insulin-like growth factor binding protein-3 links obesity and breast cancer progression
201617 citationsauthor #8
Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma☆
201638 citationsauthor #3
Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer.
201621 citationsauthor #2
Silencing overexpression of FXYD3 protein in breast cancer cells amplifies effects of doxorubicin and γ-radiation on Na+/K+-ATPase and cell survival
201617 citationsauthor #4
Abstract 1813: Insulin-like growth factor receptor and sphingosine kinase co-expression has prognostic and therapeutic potential in breast cancer
20161 citationsauthor #2
Abstract 741: Insulin-like growth factor binding protein-3 (IGFBP-3) enhances obesity-related breast tumorigenesis
20162 citationsauthor #7
Involvement of the insulin-like growth factor binding proteins in the cancer cell response to DNA damage
201522 citationsauthor #4
How IGF-1 activates its receptor
20150 citationsauthor #1
Abstract P4-04-27: Chemokines released by breast cancer-associated fibroblasts induce epithelial to mesenchymal transition in MCF7 breast cancer cells
20150 citationsauthor #4
Abstract 1047: A role for the free beta subunit of human chorionic gonadotropin in sensitivity of epithelial ovarian cancer cells to platinum-based chemotherapeutics
20150 citationsauthor #2
Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast Cancer
201542 citationsauthor #2
CCN2 requires TGF-β signalling to regulate CCAAT/enhancer binding proteins and inhibit fat cell differentiation
201510 citationsauthor #5
A novel truncated form of S100P predicts disease-free survival in patients with lymph node positive breast cancer.
201515 citationsauthor #7
IGFBP special issue – introduction
20152 citationsauthor #1
Nuclear actions of insulin-like growth factor binding protein-3.
201571 citationsauthor #1
IGFBP special issue – introduction
20150 citationsauthor #1
Proximity Ligation Assay (PLA) to Detect Protein-protein Interactions in Breast Cancer Cells
20155 citationsauthor #3
Involvement of insulin-like growth factor binding protein-3 in peroxisome proliferator-activated receptor gamma-mediated inhibition of breast cancer cell growth.
201514 citationsauthor #3
How IGF-1 activates its receptor
201577 citationsauthor #1
Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage
201521 citationsauthor #4
Abstract 2844: MIF/CD74 guided therapeutic strategy for relapsed glioblastoma patients
20140 citationsauthor #5
Cotargeting of Epidermal Growth Factor Receptor and PI3K Overcomes PI3K–Akt Oncogenic Dependence in Pancreatic Ductal Adenocarcinoma
201435 citationsauthor #9
Loss of Survival Factors and Activation of Inflammatory Cascades in the Autonomic Centers of the Brain: Implications for the Pathogenesis of Diabetic Retinopathy (DR)
20140 citationsauthor #4
Continuous positive airway pressure increases pulsatile growth hormone secretion and circulating insulin-like growth factor-1 in a time-dependent manner in men with obstructive sleep apnea: a randomized sham-controlled study.
201438 citationsauthor #4
The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents
201469 citationsauthor #4
NVP-BYL719, a novel PI3K-alpha selective inhibitor, overcomes acquired erlotinib resistance via upregulation of the PI3K/Akt/ mTOR pathway in pancreatic ductal adenocarcinoma
20140 citationsauthor #9
Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer
2014103 citationsauthor #6
Factors that May Influence the Willingness of Cancer Patients to Consent for Biobanking
201412 citationsauthor #4
CCN2 requires TGF-β signalling to regulate CCAAT/enhancer binding proteins and inhibit fat cell differentiation
20140 citationsauthor #5
IGF binding proteins in cancer: mechanistic and clinical insights
2014492 citationsauthor #1
Inhibition of Insulin-like Growth Factor–Binding Protein-3 Signaling through Sphingosine Kinase-1 Sensitizes Triple-Negative Breast Cancer Cells to EGF Receptor Blockade
201373 citationsauthor #5
Insulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions
20131 citationsauthor #1
Tissue biomarkers of breast cancer and their association with conventional pathologic features
201328 citationsauthor #7
Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
2013128 citationsauthor #8
TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
201334 citationsauthor #3
Insulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions
201396 citationsauthor #1
Abstract 616: Insulin-like growth factor binding protein-3 (IGFBP-3) facilitates the response to DNA-damaging chemotherapy in triple-negative breast cancer cells.
20130 citationsauthor #4
Protection of Blood Retinal Barrier and Systemic Vasculature by Insulin-Like Growth Factor Binding Protein-3
201229 citationsauthor #11
Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays
201231 citationsauthor #2
Differential effects of raloxifene and estrogen on body composition in growth hormone-replaced hypopituitary women.
201212 citationsauthor #6
Biochemical Characterization of Individual Human Glycosylated pro-Insulin-like Growth Factor (IGF)-II and big-IGF-II Isoforms Associated with Cancer
201236 citationsauthor #8
Interaction between IGF binding protein-3 and TGFβ in the regulation of adipocyte differentiation.
201222 citationsauthor #4
Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL.
201229 citationsauthor #4
Gonadotropin signalling in epithelial ovarian cancer.
201251 citationsauthor #2
iTRAQ-based proteomic profiling of breast cancer cell response to doxorubicin and TRAIL.
201231 citationsauthor #6
OR04-4 Endogenous insulin-like growth factor binding protein 3 (IGFBP-3) contributes to DNA damage-induced apoptosis in breast cancer cells
20120 citationsauthor #3
Abstract P5-07-05: Insulin-like growth factor binding protein-3 is a key component of the breast cancer cell response to DNA-damaging therapy
20123 citationsauthor #1
OR04-6 IGFBP-3 enhances autophagy to promote breast cancer cell survival during stress
20120 citationsauthor #4
Insulin-like growth factor binding protein-3 inhibits migration of endometrial cancer cells.
201211 citationsauthor #2
Characterization of cancer-associated IGF-II isoforms. 1 Biochemical Characterization of Individual Human Glycosylated pro-IGF-II and big-IGF-II Isoforms Associated with Cancer.*
20120 citationsauthor #9
Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS.
201217 citationsauthor #4
Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma
201225 citationsauthor #8
OR11-1 Biochemical characterisation of insulin-like growth factor II isoforms associated with tumorigenesis
20120 citationsauthor #3
Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).
201127 citationsauthor #13
Effect of intensive insulin therapy on the somatotropic axis of critically ill children.
201121 citationsauthor #7
D440N mutation in the acid-labile subunit of insulin-like growth factor complexes inhibits secretion and complex formation.
201115 citationsauthor #3
Involvement of Insulin-like Growth Factor-binding Protein-3 in the Effects of Histone Deacetylase Inhibitor MS-275 in Hepatoma Cells
201125 citationsauthor #5
Abstract 5094: Protein biomarker discovery in glioblastoma using Seldi-Tof-MS
20110 citationsauthor #4
Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3
201155 citationsauthor #2
Modulatory effect of raloxifene and estrogen on the metabolic action of growth hormone in hypopituitary women.
201013 citationsauthor #5
The effect of different patterns of growth hormone administration on the IGF axis and somatic and skeletal growth of the dwarf rat.
201012 citationsauthor #6
The chemokine CXCL 1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor
201011 citationsauthor #2
Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis
201058 citationsauthor #9
IGFBP-3 Attenuates Vascular Injury by Reducing Activation of Acid Sphingomyelinase and Retinal Vascular Permeability
20100 citationsauthor #6
Stimulation of Proliferative Pathways by IGF-binding Proteins
20101 citationsauthor #1
The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor.
2010126 citationsauthor #3
Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability.
201072 citationsauthor #2
Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase C{delta}.
201048 citationsauthor #3
PL11 Who needs IGFs? IGFBP-3 activates growth-stimulatory pathways
20100 citationsauthor #1
Effect of maternal asthma, inhaled glucocorticoids and cigarette use during pregnancy on the newborn insulin-like growth factor axis.
201044 citationsauthor #5
Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) Provides Neurovascular Protection Through Scavenging Receptor-b1 (SRB1)-Dependent Nitric Oxide (NO) Release
20101 citationsauthor #6
Potentiation of Growth Factor Signaling by Insulin-like Growth Factor-binding Protein-3 in Breast Epithelial Cells Requires Sphingosine Kinase Activity*
200983 citationsauthor #4
Effects of endogenous insulin-like growth factor binding protein-3 on cell cycle regulation in breast cancer cells
200919 citationsauthor #2
Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3.
200999 citationsauthor #4
Detection of growth hormone responsive proteins using SELDI-TOF mass spectrometry.
200913 citationsauthor #2
Proteomic profiling of growth hormone-responsive proteins in human peripheral blood leukocytes.
200918 citationsauthor #4
Insulin‐Like Growth Factors and Tumor Hypoglycemia
20090 citationsauthor #1
Activity of human pregnancy insulin-like growth factor binding protein-3: determination by reconstituting recombinant complexes.
200914 citationsauthor #3
Abstract 4883: Insulin-like Growth Factor Binding Protein-3 (IGFBP3) Modulates Vascular Tone via Scavenging Receptor-B1 (SRB1)-Dependent Nitric Oxide Release
20090 citationsauthor #3
Actions of IGF binding proteins and related proteins in adipose tissue.
200954 citationsauthor #1
Gonadotropin signalling in ovarian cancer cells – roles of calcium, PKC and Pyk2 in ERK1/2 activation
20080 citationsauthor #2

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT